Peptinovo Biopharma Inc. has invented and patented a targeted, drug-delivery platform: Peptide-Amphiphile Lipid Micelle (PALM) that reduces or eliminates chemotherapy-induced peripheral neuropathy (CIPN), one of the most serious side effects threatening treatment outcomes for world-leading chemotherapy drugs like paclitaxel.

Biotechnology

Peptinovo Biopharma

Peptinovo Biopharma's headquarters in Ann Arbor, MI, United States

This department focuses on advancing scientific research and innovation in biopharma-related fields.

Research and Development

Peptinovo Biopharma's Leadership Team includes Steve Tokarz and 2 others.

Leadership Team

This department oversees organizational strategy and policy guidance.

��

People (2)

Jobs (0)

Other teams

Leadership Team

Governance Affairs

��������

People (2)

Jobs (0)

Other teams

Leadership Team

Governance Affairs

��